INS and neuropathy: Indeed in a study of twice daily exenatide compared to basal bolus insulin over 18 months, there were no statistically significant difference in the prevalence of clinically confirmed neuropathy, intraepidermal nerve fiber density, measures of cardiac autonomic neuropathy, and nerve conductions studies.34